Freestone Grove Partners’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed -$6 1199
2026
Q1
$6 Buy
+1
New +$7 ﹤0.01% 955

Other funds holding LFST

Freestone Grove Partners's LFST Position: Q2 2026 in Review

Freestone Grove Partners sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 1 share — an estimated $6 sold.

Freestone Grove Partners first reported a position in LFST in Q1 2026 and held it in 1 quarter. The position peaked at $6 in Q1 2026. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Freestone Grove Partners reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1 Lifestance Health share in Q2 2026, an estimated $6.
  • Freestone Grove Partners first reported a position in Lifestance Health in Q1 2026 and held it in 1 quarter.
  • Freestone Grove Partners's Lifestance Health position peaked at $6 in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.